Related Experiment Video
Updated: Apr 26, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
Hierarchical mixture models for longitudinal immunologic data with heterogeneity, non-normality, and missingness.
Yangxin Huang1, Jiaqing Chen2, Ping Yin3
11 Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA.
This study introduces a new Bayesian approach for analyzing complex longitudinal medical data. The Finite Mixture of Changepoint Mixed-Effects models handle multiple response phases, population heterogeneity, non-normality, and missing data effectively.
Area of Science:
- Biostatistics
- Longitudinal Data Analysis
- Bayesian Modeling
Background:
- Longitudinal data in medical studies often exhibit complex trajectories with multiple phases (changepoints).
- Standard mixed-effects models struggle with analyzing data featuring changepoints, population heterogeneity, non-normality, and non-ignorable missingness simultaneously.
- Existing literature has limited work addressing all these complex data characteristics concurrently.
Purpose of the Study:
- To develop a novel Bayesian approach to simultaneously address multiple challenges in longitudinal data analysis.
- To introduce Finite Mixture of Changepoint (piecewise) Mixed-Effects (FMCME) models incorporating skew distributions.
- To estimate model parameters and class membership probabilities at both population and individual levels.
Main Methods:
- Developed Finite Mixture of Changepoint (piecewise) Mixed-Effects (FMCME) models using a Bayesian mixture modeling approach.
- Incorporated skew distributions to handle non-normality in the data.
- Utilized simulation studies to evaluate the performance of the proposed FMCME models.
- Applied the methodology to an AIDS clinical data example.
Main Results:
- The proposed FMCME models effectively handle longitudinal data with changepoints, heterogeneity, non-normality, and missingness.
- Simulation studies demonstrated the robustness and reliability of the Bayesian approach.
- Analysis of AIDS clinical data showcased the practical application and comparative performance of the mixture models.
Conclusions:
- The developed Bayesian FMCME models provide a flexible and powerful framework for analyzing complex longitudinal data in medical research.
- This approach offers improved quantification of treatment effects and patient care management by accounting for multiple data complexities.
- The methodology addresses a critical gap in the literature for simultaneous analysis of these challenging data features.
More Related Videos
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...

